CMIC Group, founded in 1992, is Japan's pioneering Contract Research Organization (CRO). It provides a comprehensive suite of services supporting pharmaceutical product development, including clinical trial management (Phase I-IV), contract development and manufacturing (CDMO), regulatory affairs, pharmacovigilance, market development, site support (SMO), and broader healthcare solutions. CMIC aims to accelerate the delivery of innovative treatments to patients by partnering with pharmaceutical, biotechnology, and medical device companies worldwide, as well as academic institutions.
The headquarters serves as the central command for CMIC Group's global strategy, corporate governance, R&D oversight, financial management, and administrative functions, guiding its diverse pharmaceutical service operations worldwide.
Situated in a modern, high-rise office building, the headquarters likely features contemporary office layouts designed for collaboration and efficiency, with advanced IT infrastructure to support its global operations. Its location offers excellent access to public transportation.
CMIC Group's headquarters fosters a professional, innovative, and quality-focused work culture. It blends Japanese corporate discipline with a global mindset, emphasizing teamwork, scientific excellence, ethical conduct, and a strong commitment to client success and patient well-being.
As the nerve center of Japan's first CRO, the Tokyo headquarters is highly significant. It coordinates a vast network of domestic and international operations, driving innovation in pharmaceutical development and reinforcing CMIC's leadership in the Asia-Pacific region and beyond.
CMIC Group maintains a significant global presence, with a strong foothold in Asia-Pacific (Japan, China, South Korea, Taiwan, Singapore, Australia) and North America (USA). They offer comprehensive global support for pharmaceutical development, including multi-regional clinical trials (Phase I-IV), CDMO services for drug substance and product, regulatory strategy and submissions, pharmacovigilance, market access solutions, and site management organization (SMO) services. This expansive network allows CMIC to serve clients worldwide, facilitating the complex journey of bringing new therapies to market across diverse regulatory and healthcare landscapes.
Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku
Tokyo
Tokyo
Japan
Address: CMIC, Inc., 211 Carnegie Center, Suite 301, Princeton, NJ 08540, USA
Facilitates clinical trials, regulatory submissions, and business expansion within the highly significant North American pharmaceutical sector, bridging Japanese and US pharmaceutical development.
Address: CMIC (Beijing) Co., Ltd., Room 501-506, Tower A, Horizon International Tower, No.6 Zhichun Road, Haidian District, Beijing, 100088, P.R.China
Supports domestic and international pharmaceutical companies in navigating the Chinese regulatory landscape, conducting clinical trials, and accessing the Chinese healthcare market.
Address: CMIC Korea Co., Ltd., 14F, K Twin Tower B, 50, Jongro 1 gil, Jongno-gu, Seoul, 03142, Korea
Provides localized expertise and infrastructure for conducting clinical research and supporting market entry for pharmaceutical products within South Korea.
Address: CMIC Asia Pacific, Pte. Ltd., 38 Beach Road #10-11 South Beach Tower Singapore 189767
Supports multicenter clinical trials and pharmaceutical development activities across the diverse APAC region, leveraging Singapore's position as a biomedical hub.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, CMIC Group' leadership includes:
CMIC Group has been backed by several prominent investors over the years, including:
CMIC Group announced several key leadership appointments and promotions effective October 1, 2023, aimed at strengthening its management structure and driving future growth. Most notably, Keiko Oishi was promoted to President & COO of the holding company. No major executive departures were publicly announced during this period.
Discover the tools CMIC Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CMIC Group typically uses standardized email formats for its employees, combining parts of their names with the company domain. The most common formats are believed to be the first initial followed by the last name, or first name separated from the last name by a dot. The primary domain is `cmicgroup.com`, though regional or subsidiary variations like `cmic.co.jp` might exist.
[first_initial][last]@cmicgroup.com or [first].[last]@cmicgroup.com
Format
jdoe@cmicgroup.com (for John Doe) or john.doe@cmicgroup.com
Example
75%
Success rate
CMIC Group Official Website • May 13, 2024
CMIC Group announced the opening of a new sales office in Boston, Massachusetts, USA, to enhance its Contract Development and Manufacturing Organization (CDMO) business. This strategic move aims to strengthen its presence in the North American market and better serve biotech and pharmaceutical companies in the Boston innovation hub....more
CMIC Group Official Website • April 1, 2024
CMIC Group conducted an onboarding ceremony for 185 new graduates joining the company for Fiscal Year 2024. This initiative underscores the company's dedication to fostering new talent and driving future growth across its diverse business areas....more
CMIC Group Official Website • September 6, 2023
CMIC HOLDINGS Co., Ltd. announced significant personnel changes effective October 1, 2023. These included the promotion of Keiko Oishi to President & COO, part of a broader effort to fortify its management structure for continued growth and innovation in pharmaceutical solutions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including CMIC Group, are just a search away.